Amesite Operating Co Stock price
$1.03
+0.07
7.28%
1M
-0.73
41.48%
6M
-0.86
45.50%
YTD
-2.11
67.20%
1Y
-1.48
58.96%
3Y
-20.57
95.23%
5Y
-61.61
98.36%
10Y
-61.61
98.36%
20Y
Nasdaq,
Closing price Thu, Sep 17 2026
+0.01
0.98%
Powered by
ISIN
US0310941051
Symbol
AMST
Index
Sector
Industry
Is Amesite Operating Co a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Basic
Market capitalization
$6.7m
Enterprise Value
$6.0m
Net debt
positive
Cash
$640.0k
Shares outstanding
4.7m
Valuation (TTM | estimate)
P/E
negative
P/S
19.6 | -
EV/Sales
17.8 | -
EV/FCF
negative
P/B
5.1
Financial Health
Equity Ratio
88.4%
Return on Equity
-132.1%
ROCE
-233.9%
ROIC
-
Debt/Equity
0.0
Amesite Operating Co Stock Analysis
Unlock Scores for Free
Analyst Opinions
7 Analysts have issued a Amesite Operating Co forecast:
Analyst Opinions
7 Analysts have issued a Amesite Operating Co forecast:
Buy
86%
Hold
14%
Amesite Operating Co Events
Upcoming Event
Don't miss a Thing! We will send you all news about Amesite Operating Co directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Amesite Operating Co Stock News
Neutral
GlobeNewsWire
●
4 months ago
Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care Enterprise Deployment Validates AI-Native Infrastructure Strategy and Proves Scalable, Cost-Efficient Execution in Non-Acute Care
Neutral
GlobeNewsWire
●
5 months ago
$2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants $2.6 million upfront with up to approximately $5.2 million of potential aggregate proceeds upon the exercise in full of warrants
Neutral
GlobeNewsWire
●
5 months ago
DETROIT, April 28, 2026 (GLOBE NEWSWIRE) -- Amesite Inc. (Nasdaq: AMST), developer of the AI‑native NurseMagic™ platform and EMR for non‑acute care, today announced that it has entered into definitive agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D, its Chairman and CEO, and George Parmer, a member of its board of directors, for the purchase and sale ...
Company Profile
Amesite, Inc. is a development stage artificial intelligence software company. The company is headquartered in Detroit, MI.
| Head office | United States |
| CEO | Dr. Sastry |
| Employees | 6 |
| Founded | 2017 |
| Website | amesite.com |


